Skip to main content
. 2024 Oct 24;60(11):1752. doi: 10.3390/medicina60111752
MS Mastocytosis
TEP Technical Expert Panel
PRISMA-ScR Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews
IFN-alfa Interferone alfa
SM systemic mastocytosis
SCF stem cell factor
ISM Indolent sistemic mastocytosis
KIT gene encoding tyrosine kinase protein
BMD Bone mineral density
SM-AHNMD systemic mastocytosis with associated clonal non-mast cell hematologic disease
MC mast cell
NSAIDs non-steroidal anti-inflammatory drugs
DEXA dual-energy X-Ray absorptiometry
DKK-1 Dickkopf-1
SOST sclerostin
BTM bone turnover marker
PAM pamidronate
CTX C-terminal collagen type I telopeptide
bALP bone alkaline phosphatase
FFx fractures
BMM bone marrow mastocytosis
RANKL nuclear factor kappa-B ligand
PPARγ peroxisome proliferator-activated receptor gamma
AdvSM Advanced sistemi mastocytosis
TGF-beta tumor growth factor-beta
VEGF vascular endothelial growth factor
FGF Fibroblast growth factor
WNT wingless-related integration site